Alaa Elmetwalli
Overview
Explore the profile of Alaa Elmetwalli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alokda A, Soffar A, Yousef A, Ibrahim F, El-Sewedy T, Elmetwalli A
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Mar;
PMID: 40063241
Prefoldin1 (PFDN1), a molecular chaperone, is essential for stabilizing cytoskeletal proteins like actin and tubulin, supporting cellular processes such as survival, migration, and cell cycling. Recent evidence suggests that PFDN1...
2.
Elmetwalli A, El-Sewedy T, Hassan M, Abdel-Monem M, Hassan J, Ismail N, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Dec;
PMID: 39718609
Gold nanoparticles (AuNPs) have emerged as promising candidates for cancer therapy due to their unique physicochemical properties and biocompatibility. In this study, we investigate the synthesis, characterization, and therapeutic potential...
3.
Al Balawi A, Eldiasty J, Mosallam S, El-Alosey A, Elmetwalli A
Bioresour Bioprocess
. 2024 Nov;
11(1):108.
PMID: 39604740
There is an urgent need for preventive and therapeutic drugs to effectively treat and prevent viral diseases from resurfacing as they emerge during the COVID-19 pandemic. This study aims to...
4.
Hassan M, Hamed A, Elmetwalli A, Abdel-Monem M, El-Shora H, Alsallami W
Int J Biol Macromol
. 2024 Nov;
283(Pt 3):137073.
PMID: 39549793
There has been a recent change in global attention towards addressing antimicrobial resistance (AMR) as a result of the concerning increase in mortality rates. Nanomaterials have become highly favorable options...
5.
Al Balawi A, Alblwi N, Soliman R, El-Far A, Hassan M, El-Sewedy T, et al.
BMC Pregnancy Childbirth
. 2024 Oct;
24(1):709.
PMID: 39472874
Background And Aim: Recurrent pregnancy loss (RPL), also known as recurrent implantation failure (RIF), is a distressing condition affecting women characterized by two or more consecutive miscarriages or the inability...
6.
Helal E, Elgebaly F, Mousa N, Elbaz S, Abdelsalam M, Abdelkader E, et al.
Eur J Med Res
. 2024 Sep;
29(1):459.
PMID: 39272195
Background And Aim: Metabolic dysfunction-associated steatotic liver disease (MASLD) formerly known as non-alcoholic fatty liver disease (NAFLD) is the most common liver condition globally. The FIB-4 test is used to...
7.
Almutairi A, Almutairi N, Mousa N, Elsayed A, El-Sehrawy A, Elmetwalli A
Ir J Med Sci
. 2024 Aug;
193(6):2781-2790.
PMID: 39158674
Background: Type 2 Diabetes Mellitus (T2DM) is a global health concern associated with numerous complications. Aerobic exercise is recognized as a crucial non-pharmacological intervention for T2DM management, but its specific...
8.
Hassan J, Elmetwalli A, Helal M, Al Munajer E, Hussien T, Azem Saad A, et al.
Food Chem Toxicol
. 2024 Aug;
192:114925.
PMID: 39142552
Idiopathic male infertility, a significant health concern, lacks a clear etiology. Cadmium (Cd), a widespread environmental pollutant known to impact male reproductive health negatively, can accumulate in mussels, a common...
9.
Salama A, El-Far A, Anbar E, El-Naggar S, Elshazli R, Elmetwalli A
Med Oncol
. 2024 Apr;
41(5):121.
PMID: 38647732
No abstract available.
10.
Elmetwalli A, Abdel-Monem M, El-Far A, Ghaith G, Albalawi N, Hassan J, et al.
Med Oncol
. 2024 Apr;
41(5):106.
PMID: 38575697
Recent advances in nanotechnology have offered novel ways to combat cancer. By utilizing the reducing capabilities of Lactobacillus acidophilus, silver nanoparticles (AgNPs) are synthesized. The anti-cancer properties of AgNPs have...